This month’s meningitis outbreak in Kent has prompted swift public health measures, which appear to be curbing the spread effectively. Unfortunately, two young individuals have lost their lives—one from Faversham’s sixth form and another from the University of Kent. In the Canterbury area, where the outbreak has touched four schools and two universities, thousands have had their lives disrupted, understandably sparking fear. With 18 confirmed cases and 11 more under investigation, this represents the largest cluster of meningitis cases in the UK in a generation.

The meningitis B (MenB) strain responsible for this outbreak is currently under genetic examination. In Kent, this strain has been linked to both septicaemia, or blood poisoning, and meningitis, which inflames the membranes around the brain and spinal cord. Despite the presence of meningococcal bacteria in about 10% of the population without causing harm, the reasons behind its sudden invasiveness remain a mystery, contributing to the illness’s frightening reputation due to its rapid onset and potential fatality.

However, the public health response, including contact tracing, preventive antibiotic treatment, and targeted vaccinations, appears to be effective in containing the outbreak. The NHS, drawing on decades of experience in managing such crises, has coordinated these efforts efficiently, with students adhering to recommended guidelines. Approximately 2,500 vaccines have been administered, with nearly 10,000 precautionary antibiotic doses distributed. The familiarity with infectious disease protocols, heightened by the Covid pandemic, has likely aided these efforts.

In response to the outbreak, experts are reassessing vaccine eligibility. While previous meningitis strains were more common, individuals born before 2015 have not been immunized against MenB. Some advocates are calling for broader MenB vaccination efforts. However, Health Secretary Wes Streeting wisely emphasized that such decisions should be evidence-based rather than reactionary, particularly given uncertainties about the vaccine’s long-term efficacy.

Reflecting on the past, the UK saw around 200 annual meningococcal disease-related deaths 25 years ago, a number that has remained below 40 since 2020. This reduction is a testament to the effective combination of preventive measures like vaccination and advanced treatments. England’s Chief Medical Officer, Prof Chris Whitty, notes that the more pressing public health challenges now stem from inequality and chronic illnesses.

The threat of future pandemics remains present. Recent findings from the Covid public inquiry revealed that the NHS was nearly overwhelmed, suggesting a need for bolstered infection prevention and control oversight. With the impending abolition of NHS England, ministers must clarify the ramifications for the current system. Nonetheless, the UK Health Security Agency, which succeeded Public Health England in 2021, seems effective in handling localized outbreaks, as demonstrated in Kent. As public health functions silently, it becomes crucial for both politicians and the public to recognize its indispensable role.

• Do you have an opinion on the issues raised in this article? If you would like to submit a response of up to 300 words by email to be considered for publication in our letters section, please click here.